Geron Corporation Company Profile (NASDAQ:GERN)

About Geron Corporation

Geron Corporation logoGeron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company operates through the segment, which includes discovery and development of therapeutic products for oncology. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. Imetelstat exhibits relatively preferential inhibition of the clonal proliferation of malignant progenitor cells in nonclinical studies. Janssen is engaged in the development of Imetelstat with over two clinical trials, such as a Phase II trial in myelofibrosis (MF), referred to as IMbark, and a Phase II/III trial in myelodysplastic syndromes (MDS) referred to as IMerge.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: GERN
  • CUSIP: 37416310
Key Metrics:
  • Previous Close: $2.15
  • 50 Day Moving Average: $2.12
  • 200 Day Moving Average: $2.23
  • 52-Week Range: $159,145,000.00 - $1.81
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -26.88
  • P/E Growth: -2.24
  • Market Cap: $342.16M
  • Outstanding Shares: 159,145,000
  • Beta: 2.82
Profitability:
  • Net Margins: -469.51%
  • Return on Equity: -21.96%
  • Return on Assets: -20.88%
Debt:
  • Current Ratio: 15.74%
  • Quick Ratio: 15.74%
Additional Links:
Companies Related to Geron Corporation:

Analyst Ratings

Consensus Ratings for Geron Corporation (NASDAQ:GERN) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $5.00 (132.56% upside)

Analysts' Ratings History for Geron Corporation (NASDAQ:GERN)
Show:
DateFirmActionRatingPrice TargetDetails
9/22/2016FBR & CoReiterated RatingOutperform$5.00View Rating Details
9/20/2016BTIG ResearchReiterated RatingNeutralView Rating Details
9/13/2016Piper Jaffray CompaniesReiterated RatingOverweight$10.00 -> $5.00View Rating Details
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$6.50View Rating Details
12/7/2015Oppenheimer Holdings, Inc.Reiterated RatingBuy$5.50View Rating Details
8/10/2015MLV & Co.Reiterated RatingBuy$6.00View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Geron Corporation (NASDAQ:GERN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/1/2017Q416($0.06)N/AView Earnings Details
11/3/2016Q316($0.06)($0.02)$0.22 million$5.10 millionViewListenView Earnings Details
8/3/2016Q216($0.07)($0.05)$0.38 million$0.21 millionViewListenView Earnings Details
5/5/2016Q116($0.06)($0.06)$0.26 million$0.74 millionViewListenView Earnings Details
2/25/2016Q415($0.05)($0.05)$0.32 million$0.22 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.17$17.87 million$35.40 millionViewListenView Earnings Details
8/5/2015Q2 15($0.06)($0.05)$0.40 million$0.25 millionViewN/AView Earnings Details
4/30/2015Q1($0.06)($0.06)$0.32 million$0.54 millionViewN/AView Earnings Details
3/3/2015Q4$0.17($0.06)$35.35 million$0.18 millionViewListenView Earnings Details
11/3/2014Q314($0.06)($0.06)ViewN/AView Earnings Details
8/11/2014Q214($0.06)($0.06)$0.22 million$0.34 millionViewListenView Earnings Details
5/1/2014Q114($0.06)($0.06)$0.35 million$0.47 millionViewListenView Earnings Details
3/27/2014($0.06)($0.07)ViewN/AView Earnings Details
3/17/2014Q413($0.07)($0.07)$0.35 millionViewListenView Earnings Details
11/7/2013Q313($0.06)($0.06)$0.49 million$0.18 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.07)($0.07)$0.50 million$0.11 millionViewListenView Earnings Details
4/25/2013Q1 2013($0.08)($0.09)$0.71 million$0.77 millionViewListenView Earnings Details
3/12/2013Q4 2012($0.14)($0.12)$0.50 million$0.69 millionViewListenView Earnings Details
10/30/2012Q312($0.14)($0.13)$0.38 million$0.64 millionViewN/AView Earnings Details
7/31/2012($0.15)($0.14)ViewN/AView Earnings Details
5/2/2012($0.18)($0.15)ViewN/AView Earnings Details
11/3/2011($0.18)($0.16)ViewN/AView Earnings Details
7/28/2011($0.18)($0.17)ViewN/AView Earnings Details
4/27/2011($0.19)($0.20)ViewN/AView Earnings Details
2/24/2011($0.19)($0.39)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Geron Corporation (NASDAQ:GERN)
Current Year EPS Consensus Estimate: $-0.19 EPS
Next Year EPS Consensus Estimate: $-0.08 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.06)($0.06)($0.06)
Q4 20171($0.06)($0.06)($0.06)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Geron Corporation (NASDAQ:GERN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Geron Corporation (NASDAQ:GERN)
Insider Ownership Percentage: 5.82%
Institutional Ownership Percentage: 37.66%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/29/2015Olivia Kyusuk BloomCFOSell2,380$3.84$9,139.20View SEC Filing  
3/18/2015Thomas HofstaetterDirectorSell70,000$4.10$287,000.00View SEC Filing  
5/29/2014Melissa Kelly BehrsEVPSell4,826$2.10$10,134.60View SEC Filing  
5/29/2014Olivia Kyusuk BloomCFOSell3,379$2.10$7,095.90View SEC Filing  
5/9/2014Daniel BradburyDirectorBuy142,776$1.75$249,858.00View SEC Filing  
4/1/2014Melissa Kelly BehrsEVPSell12,310$2.13$26,220.30View SEC Filing  
4/1/2014Olivia Kyusuk BloomCFOSell7,435$2.13$15,836.55View SEC Filing  
4/1/2013John A ScarlettCEOBuy50,000$1.03$51,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Geron Corporation (NASDAQ:GERN)
DateHeadline
News IconStock Watch Near-Term: Geron Corporation (NASDAQ:GERN ... - Rockville Register (NASDAQ:GERN)
rockvilleregister.com - February 25 at 5:04 AM
News IconSell-side is Weighing in on Geron Corporation (NASDAQ:GERN) Earnings - Aiken Advocate (NASDAQ:GERN)
aikenadvocate.com - February 25 at 5:04 AM
News IconAnalysts Peer Into Their Crystal Balls For Geron Corporation (NASDAQ:GERN): Where Is It headed? - Winfield Review (NASDAQ:GERN)
winfieldreview.com - February 23 at 10:26 PM
News IconFocusing on the Numbers for Geron Corporation (NASDAQ:GERN) - BVN (NASDAQ:GERN)
bvnewsjournal.com - February 23 at 10:26 PM
finance.yahoo.com logoGeron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results (NASDAQ:GERN)
finance.yahoo.com - February 22 at 11:52 AM
News IconAs the Country Crumbles, Hillary Clinton Is Clearly Living Her Best Life (NASDAQ:GERN)
naijaoversabi.com - February 19 at 4:52 PM
News IconNews Impact Score Of Geron Corporation (NASDAQ:GERN) At 100 - Stock Observer (NASDAQ:GERN)
www.thestockobserver.com - February 18 at 4:58 PM
News IconHot Stocks Report: Esperion Therapeutics, Inc. (ESPR), Geron ... - Post Analyst (NASDAQ:GERN)
postanalyst.com - February 18 at 12:28 PM
News IconChecking the Metrics on Shares of Geron Corporation (NASDAQ:GERN) - BVN (NASDAQ:GERN)
bvnewsjournal.com - February 18 at 12:28 PM
zacks.com logoGeron (GERN) Q4 Earnings: What's in Store for the Stock? (NASDAQ:GERN)
www.zacks.com - February 17 at 8:54 AM
News IconAnalyst EPS Estimates Screen: Vista Outdoor Inc. (VSTO) (NASDAQ:GERN)
www.graffiotech.com - February 15 at 4:36 AM
News IconAre Analysts Optimistic About Where Geron Corporation (NASDAQ:GERN) is Heading? - Winfield Review (NASDAQ:GERN)
winfieldreview.com - February 14 at 11:35 PM
News IconThese Two Stocks in Motion: Geron Corporation (NASDAQ:GERN), Vista Outdoor Inc. (NYSE:VSTO) - The Newburgh Press (NASDAQ:GERN)
newburghpress.com - February 14 at 6:34 PM
marketexclusive.com logoGERON CORPORATION (NASDAQ:GERN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors ... - Market Exclusive (NASDAQ:GERN)
marketexclusive.com - February 12 at 5:19 PM
biz.yahoo.com logoGERON CORP Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:GERN)
biz.yahoo.com - February 10 at 6:02 PM
News IconGeron Corporation (NASDAQ:GERN) has Current Market Capitalizaion of $331.01 Million - The Newburgh Press (NASDAQ:GERN)
newburghpress.com - February 9 at 6:08 PM
istreetwire.com logoStocks In Queue: Geron Corporation (GERN), Hudson Pacific ... - iStreetWire (NASDAQ:GERN)
istreetwire.com - February 6 at 10:27 PM
News IconGeron Corporation (NASDAQ:GERN) Quarterly EPS Projection At $-0.06 - Stock Observer (NASDAQ:GERN)
www.thestockobserver.com - February 6 at 10:27 PM
News IconEarnings Forecast Research on Geron Corporation (GERN) - Morning Outlook (NASDAQ:GERN)
www.morningoutlook.com - February 1 at 11:05 PM
News IconHoning in on Shares of Geron Corporation (NASDAQ:GERN) - Prospect Journal (NASDAQ:GERN)
prospectjournal.com - January 31 at 3:22 PM
News IconStock Review: Checking in on Share of Geron Corporation (NASDAQ:GERN) - Gilbert Daily (NASDAQ:GERN)
gilbertdaily.com - January 30 at 11:51 AM
News IconCalibrating the Trade: Watching Technicals on Shares of Geron Corporation (GERN) - Sherwood Daily (NASDAQ:GERN)
sherwooddaily.com - January 30 at 11:51 AM
News IconInvestor Monitor: Narrowing in on Geron Corporation (NASDAQ:GERN) - The Tribune (NASDAQ:GERN)
lakecitytribune.com - January 28 at 5:18 AM
News IconVimpelcom LTD Spon (VIP) Holder Shah Capital Management Upped Its Holding by $4.49 Million as Valuation Declined (NASDAQ:GERN)
randolphguide.com - January 26 at 11:53 PM
News IconAnalyst Stock Trading Analysis on Geron Corporation (GERN) - Highland Mirror (NASDAQ:GERN)
www.highlandmirror.com - January 26 at 6:51 PM
News IconGeron Corporation (NASDAQ:GERN) showed weekly volitility of 3.97% - The Newburgh Press (NASDAQ:GERN)
newburghpress.com - January 25 at 9:41 PM
fool.com logo5 Small-Cap Biotech Stocks to Buy in February (NASDAQ:GERN)
www.fool.com - January 25 at 4:27 PM
investornewswire.com logoGeron Corporation (NASDAQ:GERN) Records An Impact Score Of 0 - Investor Newswire (NASDAQ:GERN)
www.investornewswire.com - January 22 at 3:38 AM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: Geron Corporation (NASDAQ:GERN) - Wall Street Beacon (NASDAQ:GERN)
wsbeacon.com - January 21 at 5:21 PM
News IconCan This Stock Gain Any Traction: Geron Corporation (NASDAQ:GERN) - Prospect Journal (NASDAQ:GERN)
prospectjournal.com - January 18 at 10:52 PM
News IconAre These Shares a Bargain: Update on Geron Corporation (NASDAQ:GERN) - Prospect Journal (NASDAQ:GERN)
prospectjournal.com - January 17 at 3:18 PM
News IconEPS Of Geron Corporation (NASDAQ:GERN) At $-0.06 - Stock Observer (NASDAQ:GERN)
www.thestockobserver.com - January 17 at 8:28 AM
News IconCan This Stock Gain Traction: Geron Corporation (NASDAQ:GERN) - Prospect Journal (NASDAQ:GERN)
prospectjournal.com - January 17 at 8:28 AM
News IconWill The Needle Move For Geron Corporation (NASDAQ:GERN) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:GERN)
wsbeacon.com - January 17 at 8:28 AM
News IconNews Impact Score Of Geron Corporation (NASDAQ:GERN) Set At 0 - Stock Observer (NASDAQ:GERN)
www.thestockobserver.com - January 14 at 10:27 PM
News IconRisky Play or Bargain? Update on Geron Corporation (NASDAQ:GERN) - Prospect Journal (NASDAQ:GERN)
prospectjournal.com - January 13 at 8:20 AM
capitalcube.com logoGeron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : January 12, 2017 (NASDAQ:GERN)
www.capitalcube.com - January 12 at 5:51 PM
News IconGeron Corp GERN Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:GERN)
www.bioportfolio.com - January 9 at 11:15 PM
biz.yahoo.com logoGERON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Sta (NASDAQ:GERN)
us.rd.yahoo.com - January 9 at 6:14 PM
us.rd.yahoo.com logoBiotech Industry Off to a Strong Start in 2017 Latest Reports on Halozyme Therapeutics and Geron (NASDAQ:GERN)
us.rd.yahoo.com - January 9 at 6:14 PM
fool.com logo3 Reasons Geron Corporation Plunged 57% in 2016 (NASDAQ:GERN)
www.fool.com - January 5 at 8:52 AM
News IconA Look at this Riveting Stock: Geron Corporation (NASDAQ:GERN) - Prospect Journal (NASDAQ:GERN)
prospectjournal.com - January 3 at 7:44 PM
News IconGeron Corporation (NASDAQ:GERN) News Impact Score At 100 - Stock Observer (NASDAQ:GERN)
www.thestockobserver.com - December 31 at 10:22 PM
News IconBargain Hunter Investor Update on Geron Corporation (NASDAQ:GERN) - Prospect Journal (NASDAQ:GERN)
prospectjournal.com - December 30 at 5:47 PM
capitalcube.com logoETFs with exposure to Geron Corp. : December 29, 2016 (NASDAQ:GERN)
www.capitalcube.com - December 29 at 5:30 PM
News IconGrowth Story Unfolding for Geron Corporation (NASDAQ:GERN) - Prospect Journal (NASDAQ:GERN)
prospectjournal.com - December 27 at 11:25 AM
istreetwire.com logo3 Trending Stocks: Franklin Resources, Inc. (BEN), Geron Corporation (GERN), TEGNA Inc. (TGNA) - iStreetWire (NASDAQ:GERN)
istreetwire.com - December 27 at 11:25 AM
capitalcube.com logoGeron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : December 26, 2016 (NASDAQ:GERN)
www.capitalcube.com - December 26 at 11:02 AM
News IconAre There Any Catalysts to Propel Shares of Geron Corporation (NASDAQ:GERN) - Prospect Journal (NASDAQ:GERN)
prospectjournal.com - December 21 at 11:18 PM
News IconROIC in Review for Geron Corporation (NASDAQ:GERN) - OIB News (NASDAQ:GERN)
oibnews.com - December 21 at 11:18 PM

Social

What is Geron Corporation's stock symbol?

Geron Corporation trades on the NASDAQ under the ticker symbol "GERN."

Where is Geron Corporation's stock going? Where will Geron Corporation's stock price be in 2017?

3 equities research analysts have issued twelve-month price targets for Geron Corporation's stock. Their forecasts range from $5.00 to $5.00. On average, they anticipate Geron Corporation's stock price to reach $5.00 in the next year.

When will Geron Corporation announce their earnings?

Geron Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, March, 1st 2017.

Who owns Geron Corporation stock?

Geron Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include FMR LLC (14.90%), State Street Corp (2.87%), State Board of Administration of Florida Retirement System (0.09%), A.R.T. Advisors LLC (0.08%) and Metropolitan Life Insurance Co. NY (0.07%). Company insiders that own Geron Corporation stock include Olivia Kyusuk Bloom and Thomas Hofstaetter.

Who sold Geron Corporation stock? Who is selling Geron Corporation stock?

Geron Corporation's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC.

Who bought Geron Corporation stock? Who is buying Geron Corporation stock?

Geron Corporation's stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, A.R.T. Advisors LLC and Metropolitan Life Insurance Co. NY.

How do I buy Geron Corporation stock?

Shares of Geron Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Geron Corporation stock cost?

One share of Geron Corporation stock can currently be purchased for approximately $2.15.

Geron Corporation (NASDAQ:GERN) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Geron Corporation (NASDAQ:GERN)

Earnings History Chart

Earnings by Quarter for Geron Corporation (NASDAQ:GERN)

Dividend History Chart

Dividend Payments by Quarter for Geron Corporation (NASDAQ:GERN)

Last Updated on 2/27/2017 by MarketBeat.com Staff